BIIB $314.55 -5.59 (-1.75%)
Fri, Dec 14, 2018
Biogen Inc is a Health Care stock that trades on the NASDAQ with a market cap of $109.25 Billion
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen markets novel MS drugs Tysabri and Tecfidera independently. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. http://www.biogen.com
If you haven't signed up for Ebates yet, you are definitely leaving money on the table.
Get up to 12% CASH BACK from shopping @ $AMZN, $WMT and $EBAY & $10 Sign Up Bonus (through this link)!
Biogen Inc Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $322.38 which is 2.43% above the stock price of $314.55.
200 Day Moving Average
The 200 Day Moving Average is at 312.19 which is -0.76% abovethe stock price of $314.55.
Because the stock price is between the 50 DMA and 200 DMA, look at other support and resistance trendlines.
BIIB Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $314.55.
The Year To Date (YTD) return is -5.87%.
52 Week Low
The 52 Week Low stock price is $257.52 set on Mon, Apr 9, 2018 which is 251 days ago.
The current price per share is 22.15% above the 52 week low.
52 Week High
The 52 Week High stock price is $383.83 set on Wed, Jul 25, 2018 which is 144 days ago.
The current price per share is -18.05% below the 52 week high.
All Time High
The All Time High stock price is $438.43 set on Fri, Mar 20, 2015 which is 1,367 days ago.
The current price per share is -28.26% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $7.17.
The Price To Earnings (P/E) Ratio is 20.36.
Biogen Inc has a relatively low price to earnings ratio compared to the overal S&P 500 average, which is about 25%.
Some investors look for very low p/e stocks with the hopes of investing in an undervalued stock. Of course, this is just one factor to consider.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Biogen Inc was Tue, Jul 24, 2018.
Since this earnings release 145 days ago, the stock price is down by -12.17%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Tue, Oct 23, 2018, which was 54 days ago.
Since this earnings date, the stock price is down by -0.31%.
Biogen Inc Dividend
Below is important Dividend information.
BIIB currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Below are some other Biotech & Pharma industry stocks like Biogen Inc.